top of page
eMAXHealth_Masterbrand_FullColor_Hori_Logo_SMWeb.png
eMAXHealth_Systems_FullColor_Icon_Web.png

Market Access Strategy
& Research that Work Together

Market access strategy is stronger when payer, provider, and patient insights, real-world evidence, and pricing and contract strategy, and channel strategy inform one another. Too often, those inputs are developed in parallel, creating delays, disconnected recommendations, and missed opportunities to refine strategy in real time.

eMAX Health Systems brings those capabilities together through payer, provider, patient, and channel intermediary insights, real-world evidence, and pricing and contract analytics. This more connected approach helps teams make better-informed decisions across launch planning, access strategy, and ongoing optimization.

Three Solution Areas. One More Informed Access Strategy.

Explore the connected capabilities eMAX Health Systems brings together to support market access decision-making.

Market Access Strategy & Research

Businessman holding global digital globe with virtual interface icons, representing digita
MAVA_FullColor_Hori_Logo_Web.png

Generate timely payer and provider insight to inform market access strategy.

MAVA® helps pharmaceutical and biotech teams engage payer and provider stakeholders through structured research, advisory boards, and targeted insight programs. These engagements are designed to support market access planning, message refinement, reimbursement strategy, and ongoing decision-making as market conditions evolve.

  • Payer and provider advisory boards

  • Structured market access research

  • Feedback to inform launch and access planning

  • Rapid insight generation for priority decisions

HEOR & Real-World Evidence

Doctor and Patient
EMRClaims+_FullColor_Hori_Logo_Web.png

Build evidence with deeper clinical context.

EMRClaims+® supports real-world evidence generation through an EMR-first research model, with claims linkage used selectively to extend longitudinal visibility. This approach helps teams understand treatment patterns, utilization, outcomes, and the clinical factors that often cannot be seen through claims data alone.

  • EMR-first research design

  • Claims linkage where longitudinal extension adds value

  • Treatment pattern and utilization analysis

  • Evidence generation for market access and cross-functional use

Pricing, Contract & Access Strategy

Doctor Holding Prescription

Model access tradeoffs and optimize contract decisions with greater confidence.

eMAX Health Systems helps teams assess pricing sensitivity, model access implications, and evaluate contract performance using analytics designed for real-world market access decision-making. These capabilities support stronger planning before key decisions are made and more informed optimization over time.

MAVA_Elasticity_FullColor_Logo_Web.png

Elasticity™ helps teams evaluate how pricing and value decisions may influence access, utilization, and market performance. Scenario modeling supports more informed planning around pricing strategy and market response.

MAVAContractROI (1).png

Contract ROI helps teams assess rebate strategy and contract performance through analytics designed to model financial impact and access implications. This supports more informed contracting decisions and ongoing optimization.

eMAXHealth_Systems_FullColor_Icon_Web.png

Find the Right Starting Point for Your Market Access Challenge

Whether your team needs payer insight, real-world evidence, or pricing and contract strategy support,

eMAX Health Systems can help identify the right solution path.

bottom of page